Fever is strongly associated with poor outcome after traumatic brain injury (TBI). We hypothesized that early fever is a direct result of brain injury and thus would be more common in TBI than in patients without brain injury and associated with inflammation.
T raumatic brain injury (TBI) is a common, burdensome disease in the United States, as an estimated 5.3 million Americans live with disability incurred from TBI.
1 Secondary brain injury, which stems from the complex sequence of events beginning at the initial insult and continuing into the acute hospitalization, represents a potential target for intervention to limit disability after TBI. One possible cause of secondary brain injury is fever. Fever is associated with worse outcome in TBI patients, 2 as well as in experimental models of TBI. 3 In a study of over 7,000 patients with TBI, those who had high fever (>39.0°C) within 72 hours of the injury had six times the mortality of afebrile patients. 2 Even low-grade fever (38-39°C) was associated with increased mortality in this study. Moreover, fever burden, particularly early after TBI is associated with poor prognosis. 4 However, observational studies in TBI linking fever with poor outcome often lack a control group with trauma but without head injury. The incidence of early fever in major trauma without head injury is not well known, and it is unclear if fever is associated with poor outcome in the same fashion. There is evidence to suggest that early fever is associated with higher Injury Severity Scores (ISS) but not mortality in non-TBI trauma patients, leading the authors to impugn systemic inflammation as a possible cause of early fever. 5 In contrast, in TBI, it is assumed that early fever reflects injury to the brain structures responsible for homeostatic control of temperature, namely, the anterior hypothalamus. We hypothesized that early fever is a direct result of brain injury, and thus would be more common in TBI than in major trauma without brain injury. As an exploratory aim, we measured seven key cytokines (interleukin [IL] 1beta, IL-2, IL-4, IL-6, IL-8, IL-10, and tumor necrosis factor [TNF]-alpha) at two timepoints (admission, 24 hours after trauma) to assess the systemic inflammatory responses in febrile and afebrile patients.
PATIENTS AND METHODS

Patients, Protocols
We prospectively enrolled major trauma patients with and without TBI from a busy Level I trauma center intensive care unit (ICU) from October 2013 through June 2015. Major trauma was defined as injuries sufficient to warrant ICU admission. All patients meeting this criterion were approached for informed consent. Patients refusing consent, that could not be consented, or who were not admitted to the ICU were excluded. For patients with severe brain injury who were unable to provide informed consent themselves, consent was obtained from the patient's legally authorized representative. If and when they regained the ability to provide consent during the hospitalization, the patient was approached to reaffirm consent. Per ICU protocol, temperatures were recorded at least every 4 hours (and as frequent as hourly) for the first 48 hours after admission. Early fever was defined as at least one recorded temperature higher than 38.3°C in the first 48 hours after admission. Temperatures were measured with an oral probe in the majority of measurements. A bladder catheter thermistor or rarely, an axillary probe was used if the oral route was inaccessible. If the temperature threshold of 38.3°C was met or exceeded, cultures of blood and urine, as well as sputum for intubated patients, were routinely obtained, unless the patient was immediately postoperative (<24 hours). Additionally, febrile patients received interventions in a tiered fashion, starting with acetaminophen, followed by external cooling measures, such as ice packs or cooling blankets if medication alone was ineffective after the first hour. If these measures were ineffective, an adhesive cooling device was applied. The institutional review boards approved the study before screening of any patients.
Definitions, Variables, Outcome Measures
Information regarding the hospital course was abstracted from the electronic medical record and included ICU length of stay (LOS), hospital LOS, death during the admission, Glasgow Coma Scale (GCS) score at time of discharge from ICU, Glasgow Outcome Scale-Extended (GOSE) at the time of hospital discharge. Abbreviated Injury Scale (AIS) scores for each body region and overall ISS were abstracted from the trauma registry. Patients were assigned to one of four groups based on their presenting Head Abbreviated Injury Severity Scale score:
1. Multiple injuries: head AIS score greater than 2, one other region greater than 2 2. Isolated head: head AIS score greater than 2, all other regions less than 3 3. Isolated body: one region greater than 2, excluding head/face 4. Minor injury: no region with AIS greater than 2 Hypotension was defined as systolic blood pressure less than 90 mm Hg and hypoxia was defined as oxygenation saturation less than 90% measured in the field or on admission to the emergency department. Shock was recorded by measuring base deficit in mEq/L. Culture-verified infection was determined if a culture drawn within 48 hours of admission grew a pathogenic organism not felt to be a contaminant.
Cytokine Measurement
Plasma samples were obtained on admission (<8 hours from the trauma) and at 24 hours after injury, and banked at −80°C for subsequent analysis. Plasma was analyzed using a Luminex human analyte platform that screens secreted proteins using multiplex fluorescent immunoassay; samples were run in duplicate for confirmation, and the medians [interquartile range] in pg/mL reported. To control data quality, if more than 20% of measurements were below the threshold of detection, the cytokine value was not included for further analysis.
Statistical Methods
Descriptive statistics (median and interquartile range for continuous variables; frequencies and percentages for categorical variables) were used to describe clinical data by group. Group comparisons for categorical variables were performed using Fisher's exact tests and ordinal comparisons were made with the Wilcoxon-Mann-Whitney test for two group comparisons, and the Kruskal-Wallis H test for three group comparisons. Nonparametric methods were used for ordinal data and continuous data that were highly skewed. A total sample size of 268 patients was determined to detect a 15% difference in the incidence of fever between patients with and without brain injury, using a two-sample comparison of proportions with alpha = 0.05 and power = 0.80. Statistical analysis was performed using Stata software (Stata 12, StataCorp, College Station, TX). Significance was set at p value of 0.05 or less.
RESULTS
Subject Characteristics by Trauma Group
Over 500 patients who sustained trauma were screened (n = 510), and 268 patients were enrolled; including subjects with multiple injuries (n = 59), isolated head (n = 97), isolated body (n = 100), and minor trauma (n = 12) (Fig. 1) . Patients with minor injury were excluded from further analysis, because these subjects did not qualify as having major trauma (no body region with AIS > 2). Subjects in the multiple injuries group were more seriously injured than the other two groups, having higher median ISS, lower GCS score on admission and higher median base deficit. Patients with isolated head injury were older than those patients with isolated body or multiple injuries (n < 0.01). Likewise, rates of admission hypoxia and admission hypotension were uncommon and similar between all three groups ( Table 1 ). The incidence of fever was similar in all three groups ( p = 0.126), ranging from 11% to 24%. About half (52%) of the patients were treated with acetaminophen in the first 48 hours for the indication of fever, and 11% required a cooling blanket for fever control. No patients required an adhesive cooling device for refractory fever.
Early Fever Status, Injury Severity, and Inflammation by Trauma Group
More severe injury was not associated with fever status, except in the isolated head injury group. In the isolated head injury group, febrile patients were sicker than afebrile patients, specifically with febrile patients having significantly higher ISS (26 [19] [20] [21] [22] [23] [24] [25] [26] [27] vs. 17 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , p = 0.0015), lower admission GCS (14 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] vs. 15 [14] [15] , p = 0.0008), and higher head AIS (5 [4] [5] vs. 4 [3] [4] , p = 0.0023). There was no association between fever and injury severity (ISS) in the multiple injuries or isolated body injury groups. Culture-verified infection rates were similar between febrile and afebrile patients in all three groups (Table 2 ). There were no differences in hypoxia or hypotension on admission by fever status in any of the three groups.
Inflammation and Outcome by Fever Status
In all three groups, there was a significant association between fever and poor outcome, specifically death in the hospital, as well as longer ICU stays. Fever was also associated with worse median discharge GOSE in both the multiple injuries and isolated head injury groups. Patients in the multiple injuries group with fever had a longer hospital stay than those without fever (Table 2) .
Patients in all three injury groups had similar admission and 24-hour values of the cytokines we examined including IL-1beta, IL-4, and TNF-alpha, regardless of fever status (Table 3) . A notable exception was IL-6, which was significantly elevated in patients with fever in the isolated head injury group on admission, which persisted at 24 hours. In addition, median IL-6 rose in the febrile patients with isolated body injury at the 24-hour mark. We also observed elevations of IL-2 in the nonfebrile multiple injuries patients at 24 hours, and elevations in IL-10 in the febrile isolated head injured patients at 24 hours (Table 3) . IL-8 was excluded from further analysis because greater than 20% of the values we obtained were below the detection threshold.
DISCUSSION
Contrary to our original hypothesis, the incidence of early fever in trauma patients appears to be similar, regardless of the presence of brain injury, though the pattern of inflammation might be unique in isolated TBI with regard to IL-6 levels. Our study is the largest prospective cohort study to examine fever in trauma patients with and without TBI. Our estimate of the incidence of fever is in line with prior studies of early fever in neurologically injured patients, 6 and echoes a smaller study of fever in critically ill trauma patients where no difference in incidence of fever was observed between patients with TBI and without TBI. 5 That study by Bengualid et al. was a retrospective report of 162 trauma patients with and without TBI. We observed a lesser incidence of early fever than in the Bengualid study (16% vs. 40%), possibly because we chose a more stringent definition of fever (>38.3°C vs. >38.0°C). The more stringent temperature demarcation is in line with previous studies of fever in neurologically injured patients, 7 as well as a position statement from the American College of Critical Care Medicine recommending defining fever as any temperature above 38.2°C in intensive care unit patients. 8 Our observations contrast with a retrospective study of critically ill patients, which found fever to be more common in neurologically injured subjects. 9 However, this study included few trauma patients (<10%) and defined fever as any temperature at 37.5°C or greater during the first 24 hours of hospitalization.
Fever was associated with in-hospital mortality, similar to other observational studies of neurologically injured patients, 2, 6, 9 but in opposition to the Bengualid study. 5 Caution should be applied in the interpretation of our findings, however, because mortality was a relatively rare event in our study. Fever was associated with prolonged ICU stay in all of the groups. Unfortunately, we do not have data on how fever impacted outcome in the non-neurologically injured isolated body trauma group beyond hospital stay. Other authors have found that early elevations in temperature in a mixed trauma population might be protective, and that lack of fever on days 1 and 2 was associated with higher rates of infection and mortality. 10 Notably, this study excluded trauma patients with severe head injury. Similar to these investigations, we observed a low rate of documented infection to accompany early fever.
Early fever is consistently associated with poorer outcomes in patients with brain injury. In a large, retrospective study of Chinese head trauma patients, both the degree and duration of early (<72 hours posttrauma) fever were strongly related with the outcomes of patients with acute TBI. 2 The intensity dependency suggests that fever might contribute to secondary brain injury. Experimentally induced hyperthermia exacerbates pathophysiologic processes, such as lexcitotoxicity, apoptosis, and inflammation. 11 However, efforts to eliminate fever, including hypothermia, have not been shown to improve outcomes clinically. 12, 13 These initial results might reflect our incomplete understanding of the relationship between fever and poor outcome in braininjured patients.
Investigators have speculated that the association between fever and lower GCS on presentation is related to the severity of the neuronal injury, 14 particularly diffuse axonal injury and frontal lobe injury. 15 Hypothalamic injury with loss of temperature regulation is often cited as the mechanism underlying noninfectious or neurogenic fever. 7, [16] [17] [18] It is possible that the relationship is broader and might not require hypothalamic injury. Tissue trauma and the subsequent cascade of aseptic inflammation may lead to the generation of fever similar to the response to exogenous pyrogens. In classic models of infectious fever, endogenous pyrogenic cytokines (IL-1, IL-6, and TNFalpha) are released into the bloodstream, stimulate production of prostaglandins in the central nervous system, resulting in [4] [5] [6] [7] [8] n/a n/a thermogenesis mediated by the anterior hypothalamus, 19 though this is only one of several pathways resulting in temperature elevation. 20 Our study suggests a persistent association between early fever and elevated levels of IL-6 peripherally in isolated head injury, though it is impossible to infer cause or effect. Elevated peripheral levels of IL-6 after TBI have been associated with elevated ICP 21 and poor outcome 22, 23 in some studies, whereas other authors observed no relationship with outcome. 24 It is unclear why the association between elevated IL-6 and fever was not observed in patients with multiple injuries who also have brain injury. The later rise of IL-6 at 24 hours in the isolated body injury group might be related to operative repair of orthopedic injuries that often occurs on day 1 after injury, but this hypothesis would need to be directly tested. In TBI, rises in IL-10 peripherally have been associated with elevated intracranial pressure and sympathetic nervous system activation, 25 which might help to explain the association between fever and elevated IL-10 we observed at 24 hours in our isolated head injury group. IL-2 production peaks at 24 hours after injury and can be suppressed by more severe injury, 26 which may explain the reduction in the IL-2 level in the febrile multiple injuries patients at 24 hours. Future research might interrogate the association between IL-6 and fever by altering plasma IL-6 levels and measuring the impact on fever burden and outcomes in patients with brain injury.
Limitations
Our study has several important limitations. Temperatures were not uniformly measured in all patients and ranged from as frequently as hourly to once every 4 hours, potentially leading to missing data. It is possible that the pattern of missing data was nonrandom, introducing bias. Transient temperature elevations might have been missed, underestimating the incidence of fever. Temperatures were measured from different sources, including oral (66%), bladder (20%), and axillary (14%), which may have introduced additional variability, though oral temperatures are thought to represent core temperatures relatively well, even in the critically ill. 27 Axillary measurements may underestimate core temperatures (by 0.33 ± 0.55°C in one study of critically ill adults), 28 potentially underestimating the incidence of fever. Additionally, we did not measure the efficacy of fever therapy, and we do not know if fever therapy altered the outcome of our febrile patients. Despite the protocoled, tiered approach to fever outlined in the methods, only about half of febrile patients received antipyretic medication. This is perhaps due to the short duration of the temperature elevation. Another important limitation was that not all infections are culture positive, and thus occult infections may have been missed. We selected the first 48 hours as the window for early fever to capture noninfectious fever, as other investigators have found that fever documented within 72 hours of admission predicts negative evaluation for infection. 29 It is unclear what role, if any, fever or brain trauma played in the decision to convert to comfort care in the eight patients who died in hospital. Future studies should account for withdrawal of life-sustaining measures to better address the relationship between mortality and fever. Finally, a few of our subjects were missing 24-hour cytokine levels. It is possible that the pattern was nonrandom introducing bias, though most subjects did have 24-hour values (83%, 212/256).
CONCLUSION
Early fever is common in trauma, with or without brain injury. Early fever may be a consequence of tissue trauma with resultant aseptic inflammation rather than hypothalamic damage. It remains to be shown whether altering or preventing early fever improves outcomes after trauma. Future studies should investigate the relationship between fever and aseptic inflammation, using consistent temperature measurements with a view to intervention. AUTHORSHIP H.E.H. participated in the study design, data collection, data analysis, data interpretation, and writing. S.R. participated in the data collection, data interpretation, and revision. A.L.L. participated in data analysis, and data interpretation. C.M. participated in study design and revision. M.A.Sc. participated in study design and critical revision.
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